期刊文献+

表皮生长因子受体在原发性胆囊癌中的表达及其预后意义 被引量:1

The Expression of Epidermal Growth Factor Receptors(EGFR) in Primary Gallbladder Carcinoa(PGC) and its Relation with Prognosis
下载PDF
导出
摘要 目的:探讨表皮生长因子受体(EGFR)在原发性胆囊癌中的表达及其预后意义。方法:38例原发性胆囊癌石蜡包埋标本,免疫组织化学SP法。结果:EGFR在原发性胆囊癌中表达的阳性率为(57.6±36.7)%,表达呈异质性,EGFR计数与术后生存期呈显著负相关(P<0.05)。EGFR高值组生存期与低值组比较有显著差异(P<0.05),EGFR计数与肿瘤的分化程度、浸润深度呈显著相关关系(P<0.05)),与病理类型及淋巴结转移,无显著相关性。结论:EGFR表达对判断原发性胆囊癌的预后有一定的参考价值。 Objective:The purpose of this paper was to investigete the expression of EGFR in PGC tissue and its signiticance for prognosis Methods:Thirty eight pareffin embedded specimens from primary gallbladder carcinoma tissue were collected. They were examined immunohistochemically.Results:The positive rate of EGFR product in gallbladder cancer tissue was (57.6±36.7)%. The EGFR labelling Index (LI) showed a significant negative correlation with survival of patients after curative resection (P<0.05). The survival periods ware significantly different in patients with low and high EGFR LI. The expression of EGFR correlated significantly with differentiation and invasion (P<0 05), but did not correlate with their pathohistological types and lymph node metastasis.Conclusion:The detection of EGFR in PGC tissue may be useful in judging the prognosis for PGC.
出处 《中国医科大学学报》 CAS CSCD 北大核心 1998年第1期42-44,共3页 Journal of China Medical University
关键词 胆囊肿瘤 表皮生长因子 受体 预后 EGFR gallbladder carcinoma epidermal growth factor receptor prognosis
  • 相关文献

同被引文献25

  • 1武华,赵靖,李正中,梁光荣.PCNA在胆囊癌中的意义[J].肿瘤研究与临床,1996,8(3):149-150. 被引量:3
  • 2Wistuba II , Albores - Saavedra J. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobil Pancreat Surg, 1999,6(3) : 237 - 244.
  • 3Mikami T, Yanagisawa N, Baba H, et al. Association of Bcl - 2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. Cancer, 1999,85(2) : 318- 325.
  • 4Tatsumoto T, Nakano S, Shimizu K, et al. Direct tumorigenic conversion of human gallbladder carcinoma cells by v - src but not by activated c- H- ras oncogene. Int J Cancer, 1995,61(2) : 206-213.
  • 5Lee CS. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours. Eur J Surg Oncol, 1998, 24(1).. 38-42.
  • 6Itoi T, Shinohara Y, Takeda K, et al. Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J Gastroenterol,2000,35(2) : 142 - 149.
  • 7Saetta A, Lazaris AC, Davaris PS. Detection of ras oncogene point mutation and simultaneous proliferative fraction estimation in gallbladder cancer. Pathol Res Pract, 1996,192(6) :532 - 540.
  • 8Iwase T, Nakazawa S, Yamao K, et al. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary duets. Hepatogastroenterology, 1997,44 ( 17 ) : 1457- 1462.
  • 9Roa I, Aretxabala X, Araya JC, et al. Incipient gallbladder carcinoma - clinical and pathological study and prognosis in 196 cases.Rev Med Chil, 2001,129(10): 1113- 1120.
  • 10Chow NH, Huang SM, Chan SH, et al. Significance of c- erbB- 2 expression in normal and neoplastic epithelium of biliary tract.Anticancer Res, 1995,15(3): 1055- 1059.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部